Navamedic ASA (OSL:NAVA)

Revenue by Segment

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals, Medical Nutrition and Consumer Health Products	565.36M	531.44M	512.00M	382.14M	278.44M
Total	565.36M	531.44M	512.00M	382.14M	278.44M

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Norway	194.83M	201.65M	214.12M	198.89M	138.05M
Sweden	197.87M	185.54M	158.92M	96.74M	59.88M
Denmark	51.21M	38.86M	38.07M	28.15M	27.61M
Finland	50.09M	36.24M	27.71M	17.95M	13.85M
The Netherlands	49.13M	34.75M	54.01M	26.37M	-
Other countries	22.24M	34.40M	19.18M	14.05M	39.06M
Total	565.36M	531.44M	512.00M	382.14M	278.44M

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error